Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies

Clinical trial NCT07004244 · RECRUITING

Trial details

NCT number: NCT07004244
Sponsor: Sichuan University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Tumors

Start date: 2025-06-05
Primary completion: 2027-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.